The tumor suppressor gene p53 is a potent transcriptional regulator of genes which are involved in many cellular activities including cell cycle arrest, apoptosis, and angiogenesis. Recent studies have demonstrated that the activation of the transcriptional factor nuclear factor kB (NF-kB) plays an essential role in preventing apoptotic cell death. In this study, to better understand the mechanism reponsible for the p53-mediated apoptosis, the eect of wild-type p53 (wt-p53) gene transfer on nuclear expression of NF-kB was determined in human colon cancer cell lines. A Western blot analysis of nuclear extracts demonstrated that NF-kB protein levels in the nuclei were suppressed by the transient expression of the wt-p53 in a dose-dependent manner. Transduced wt-p53 expression increased the cytoplasmic expression of IkBa as well as its binding ability to NF-kB, thus markedly reducing the amount of NF-kB that translocated to the nucleus. The decrease in nuclear NF-kB protein correlated with the decreased NF-kB constitutive activity measured by electrophoretic mobility shift assay. Furthermore, parental cells transfected with NF-kB were better protected from cell death induced by the wt-p53 gene transfer. We also found that the wtp53 gene transfer was synergistic with aspirin (acetylsalicylic acid) in inhibiting NF-kB constitutive activity, resulting in enhanced apoptotic cell death. These results suggest that the inhibition of NF-kB activity is a plausible mechanism for apoptosis induced by the wt-p53 gene transfer in human colon cancer cells and that anti-NF-kB reagent aspirin could make these cells more susceptible to apoptosis. Oncogene (2000) 19, 726 ± 736.
Introduction
The p53 tumor suppressor gene is involved in multiple central cellular processes as a potent transcriptional regulator, and one of its most important roles is the induction of apoptosis (Harris, 1996) . We previously reported that the overexpression of the wild-type p53 (wt-p53) gene by recombinant, replication-de®cient viral vectors induced apoptosis in a variety of human cancer cells diering in their p53 status (Fujiwara et al., 1994a,b; Kagawa et al., 1997; Ogawa et al., 1997) . The elucidation of the molecular mechanism of p53-mediated apoptosis would provide insights into the mode of action of DNA-damaging conventional cancer therapies, including chemotherapeutic agents and ionizing radiation, as well as the development of novel cancer gene therapies using the wt-p53 gene.
The transcription factor nuclear factor kB (NFkB) has attracted widespread attention among researchers in many ®elds. NF-kB consists of two major polypeptides, p50 and p65. It exists in cells as an inactive cytoplasm precursor by complexing with the inhibitor IkB. Stimulation triggers the release of NF-kB from IkB, resulting in the translocation of NF-kB from the cytoplasm to the nucleus, where NF-kB binds DNA and regulates the transcription of speci®c genes . There is increasing evidence that activation of NF-kB is part of a regulatory mechanism that prevents apoptosis induced by the cytokine, tumor necrosis factor-a, ionizing radiation, and chemotherapeutic agents, most likely by inducing the expression of antiapoptotic genes (Beg and Baltimore, 1996; Wang et al., 1996 Wang et al., , 1998 Van Antwerp et al., 1996; Wu et al., 1998; Stehlik et al., 1998) . Recent studies have demonstrated that constitutive NF-kB activation in the nucleus induces cellular resistance to apoptosis and that, in contrast, inhibition of nuclear NF-kB activity sensitizes the cells to killing (Giri and Aggarwal, 1998; Bellas et al., 1997) . These observations led us to hypothesize that an overexpression of the wt-p53 gene might down-regulate the constitutive NF-kB activity in human cancer cells.
In the present study, we found that an adenovirus-mediated wt-p53 gene transfer into human colon cancer cells caused a decrease in the endogenous levels of nuclear-localized NF-kB, which was correlated with suppressed NF-kB constitutive activity, thereby leading to a rapid induction of apoptosis. Our data provide a novel and signi®cant insight into the mechanism of p53-mediated apoptosis, thus giving clues to facilitate the development of p53 gene-based replacement therapy.
Results

Inhibition of expression and nuclear translocation of NF-kB by wt-p53 gene transfer
A replication-de®cient adenovirus vector carrying a wtp53 gene under the control of the cytomegalovirus (CMV) promoter (Ad5CMVp53) was generated to achieve ecient gene transfer into human cancer cells. Infection with Ad5CMVp53 signi®cantly induced apoptosis on human colon cancer cell lines DLD-1, which is homozygous for a mutation in p53, and LoVo, which contains wt-p53 (data not shown), as previously reported Fukazawa et al., 1999) .
To clarify the molecular mechanism of the Ad5CMVp53-mediated anti-tumor eects, we tested whether wt-p53 gene transfer could alter nuclear NFkB protein levels. The Western blot analysis of nuclear extracts indicated that both the p65 and p50 subunits of NF-kB were readily detectable in the nuclei of DLD-1 and LoVo cells, and that their immunoreactivities were markedly reduced 36 h after Ad5CMVp53 infection, in a dose-dependent manner ( Figure 1a ). The decrease of nuclear NF-kB protein levels was inversely correlated with the increased nuclear p53 protein expression that included endogenous mutant p53 and transduced wt-p53. As one of the events that is known to occur during NF-kB activation, the p65 subunit translocates to the nucleus, which is an essential event in preventing apoptotic cell death. The present immuno¯uorescent analysis showed more intense cytoplasmic staining of the p65 subunit in Ad5CMVp53-infected DLD-1 cells compared to mockor dl312-infected cells in a dose-dependent manner (Figure 1b) , indicating that the p53-mediated reduction of nuclear NF-kB protein might be the partial result of a decrease in nuclear translocation.
We further examined whether the wt-p53-mediated down-regulation of nuclear expression of the NF-kB p65 subunit correlated with the reduction of constitutive NF-kB DNA binding activity. The EMSA revealed that, as we expected, DLD-1 and LoVo cells constitutively expressed NF-kB binding activity and the activity was suppressed following Ad5CMVp53 infection, in a dose-dependent manner, whereas the NF-kB binding activity remained unchanged in cells infected with control dl312 vector (Figure 1c ). To determine speci®city of the wt-p53-mediated down-regulation of NF-kB, EMSA was performed with probes for SP-1 and AP-1. As shown in Figure 1d , none of the levels of these transcriptional factors was altered. Thus, downregulation of NF-kB by the wt-p53 gene transfer appears to be a speci®c response.
Increased IkBa interaction with NF-kB in the cytoplasm by wt-p53 gene transfer It is known that NF-kB dimers are normally sequestered in an inactive cytoplasmic complex by binding to its inhibitory subunit, IkB. To further examine the mechanism of the wt-p53-mediated inhibition of NF-kB nuclear translocation, the cytoplasmic expression of IkBa protein (a member of the IkB family) was analysed by Western blot analysis and immuno¯uorescent staining. Western blot analysis of cytoplasmic extracts indicated that IkBa immunoreactivity was markedly increased 8 h after Ad5CMVp53 infection (30 MOI) in DLD-1 cells and 16 h after Ad5CMVp53 infection (100 MOI) in LoVo cells (Figure 2a ). DLD-1 cells were infected with Ad5CMVp53 at a MOI of 10 or 30, or dl312 at a MOI of 30, and then stained with a speci®c antibody against IkBa 8 h after infection. Indirect immuno¯uorescence analysis showed more intense cytoplasmic staining of IkBa in Ad5CMVp53-infected cells compared to that of mock-infected cells (Figure 2c ). In contrast, Western blot analysis using a phospho-speci®c IkBa antibody revealed that Ad5CMVp53 infection inhibited phosphorylations on IkBa in both DLD-1 and LoVo cells (Figure 2b) .
We next tested whether IkBa could increase the binding activity with NF-kB in the cytoplasm following the wt-p53 gene transfer. The cytoplasmic extracts were obtained from parental cells and cells infected with either Ad5CMVp53 or dl312 (at 30 MOI for DLD-1 cells and at 100 MOI for LoVo cells), and then immunoprecipitated by incubation with anti-IkBa antibody. Analysis of the immunoprecipitate by Western blot revealed a dramatic increase in NF-kB p65 levels bound to IkBa after Ad5CMVp53 infection (Figure 2d ). These results indicate that the wt-p53 gene transfer could up-regulate the cytoplasmic IkBa expression as well as increase its binding activity with NF-kB, leading to the inhibition of NF-kB nuclear translocation.
Overexpression of nuclear NF-kB expression induces resistance to wt-p53-mediated apoptosis in DLD-1 cells
The results described above suggest that down-regulation of the nuclear NF-kB expression is likely a mechanism for apoptosis induced by the wt-p53 gene transfer. If this is indeed the fact, overexpression of nuclear NF-kB would be expected to counteract and rescue the wt-p53-induced apoptotic cell death in DLD-1 cells. To test this possibility, DLD-1 cells were stably transfected with human NF-kB p65 cDNA. As shown in Figure 3a , cells transfected with the control plasmid pcDNA3.1(+) predominantly expressed endogenous NF-kB in the cytoplasm, whereas ectopically expressed NF-kB p65 was distributed in the nucleus, as evidenced by the intense immuno¯uorescent nuclear staining, in cells transfected with the pcDNA3.1(+)/p65 plasmid.
Transfected DLD-1 cells were infected with Ad5CMVp53 at a MOI of 30 and the cell viability was assessed by measuring Trypan blue uptake 24 h after infection. DLD-1 cells ectopically expressing the NF-kB p65 subunit were signi®cantly more resistant to wt-p53-mediated cytotoxicity compared to cells transfected with the control plasmid (P50.01) (Figure 3b ). These results suggest that overexpression of NF-kB can at least in part prevent DLD-1 cells from undergoing apoptosis triggered by the wt-p53 gene transfer.
Effects of aspirin on NF-kB inhibition and apoptosis induced by wt-p53 gene transfer
The common molecular target of aspirin is known to be the blockade of NF-kB induction (Grilli et al., 1996; Kopp et al., 1994) . We tested whether aspirin could increase the down-regulation of nuclear NF-kB following the wt-p53 gene transfer. DLD-1 cells were exposed to Ad5CMVp53 at a MOI of 5 in the presence or absence of 3 mM aspirin, which is a concentration used in the treatment of rheumatic disease in humans (Insel et al., 1990) , and the nuclear extracts were subjected to a EMSA. As shown in Figure 4a , Ad5CMVp53 infection in the presence of aspirin show a greater suppression of NF-kB constitutive binding activity 36 h after treatment compared to Ad5CMVp53 alone.
We next investigated whether aspirin could enhance the antitumor eects of wt-p53 gene transfer. DLD-1 cells were infected with Ad5CMVp53 at a suboptimal dose of 5 MOI, and then continuously treated with 3 mM of aspirin. Cell viability was assessed over 5 days by measuring Trypan blue uptake. As shown in Figure 4b , Ad5CMVp53 infection alone induced a gradual decrease of the cell viability, whereas a rapid reduction of cell number was observed in DLD-1 cells treated with both Ad5CMVp53 and aspirin. By 24 h there was a marked dierence between the results of these two treatments. Aspirin alone showed a mild inhibitory eect on the growth of DLD-1 cells, but not on cell viability.
Finally, to con®rm the induction of apoptosis by suboptimal Ad5CMVp53 in combination with aspirin, DLD-1 cells exposed to Ad5CMVp53 and aspirin were harvested at 72 h post-treatment and then assayed for DNA contents by a¯owcytometric analysis. Ad5CMVp53-infected DLD-1 cells exhibited a DNA content less than the diploid G0/G1 peak, indicating apoptosis-speci®c nuclear fragmentation; the combined treatment with Ad5CMVp53 and aspirin, however, showed an enhancement of killing over Ad5CMVp53 alone (i.e., sub-G0/G1 fraction: 14.05% vs 35.51%) (Figure 4c) . Apoptosis was also shown by the typical ladder' pattern of DNA fragmentation (Figure 4d ).
Discussion
We have demonstrated that the wt-p53 gene transfer by a recombinant adenovirus vector induced apoptosis through a down-regulation of constitutive NF-kB Figure 1 (a) Detection of p53 and NF-kB proteins in adenovirally transduced cells by Western blot analysis. The human cancer cell lines DLD-1 and LoVo were transduced with the wt-p53 gene. DLD-1 cells were infected with either Ad5CMVp53 or dl312 at a MOI of 5, 10, or 30, and LoVo cells were infected with Ad5CMVp53 at a MOI of 10, 50, 100 or dl312 at a MOI of 100. Transduced cells were then collected 36 h after infection. Equivalent amounts of nuclear extracts (15 mg) obtained from whole cell lysates were loaded in each lane, probed with anti-NF-kB p65, anti-NF-kB p50, or anti-p53, and then visualized with an ECL detection system. (b) Cytoplasmic expression of NF-kB p65 protein by immuno¯uorescent staining. DLD-1 cells were infected with Ad5CMVp53 at 5, 10, 30 MOI or dl312 at 30 MOI, and stained with a speci®c antibody against the p65 subunit of NF-kB. NF-kB staining appeared to be concentrated in the cytoplasm 8 h after Ad5CMVp53 infection. (c) Equal amounts of the same nuclear extracts as those described in (a) were subjected to EMSA with 32 P-labeled oligonucleotide probe containing the NF-kB DNA binding sites. The arrow head indicates NF-kB. Dose-dependent inhibition of NF-kB activity was achieved by Ad5CMVp53 infection alone. NF-kB binding activity remained unchanged in cells infected with control dl312 vector. (d) Nuclear extracts were also probed with SP-1 and AP-1 binding oligonucleotides DNA binding activity in human colon cancer cell lines. Moreover, the nonsteroidal antiin¯ammatory drug aspirin acted synergistically with wt-p53 gene transduction in suppressing NF-kB constitutive activity as well as triggering apoptosis. These data indicate a link between p53 activity and NF-kB suppression, which has a signi®cant implication for the development of p53 gene-based replacement therapy for human cancer.
The overexpression of NF-kB has been linked to the development of tumors as evidenced by the ®ndings that cell lines derived from colon, ovarian, and nonsmall cell lung carcinomas expressed high levels of NFkB (Bours et al., 1994; Mukhopadhyay et al., 1995) . Progressive activation of constitutive NF-kB in the nucleus has also been correlated with the progression of breast cancer, melanoma, and juvenile myelomonoInhibition of NF-kB activity by p53 and aspirin J Shao et al cytic leukemia (Nakshatri et al., 1997; Raziuddin et al., 1997; Shattuck-Brandt and Richmond, 1997; Kochetkova et al., 1997) . In contrast, an inhibitor of NF-kB function has been shown to suppress tumorigenicity and lead to the regression of established tumors (Higgins et al., 1993) . A major cause of embryonic death of mice lacking the p65 subunit of NF-kB is massive apoptosis of liver cells (Beg et al., 1995) .
Experiments showing that activated NF-kB could induce the expression of anti-apoptotic genes such as IEX-1L and the IAP family (Wu et al., 1998; Stehlik et al., 1998; Wang et al., 1998) suggest that NF-kB activation acts as a primary mechanism to protect cells against genotoxic apoptotic stimuli. The activation of NF-kB is regulated by its intracellular location, which is independent of protein synthesis. Our data indicate that the nuclear NF-kB subunits p65 and p50 were decreased by wt-p53 gene transfer (Figure 1a) . The simplest explanation of the present results is that transduced wt-p53 blocked the translocation of NF-kB from the cytoplasm to the nucleus, which was con®rmed by the ®nding that the wt-p53 gene transfer resulted in an intensive cytoplasmic accumulation of p65 protein (Figure 1b) . The transcriptional activation of NF-kB occurs largely through the stimulation of the p65 subunit, suggesting the importance of this phenomenon. Recently, it has been reported that p53 inhibits p65-dependent transactivation without altering NF-kB p65 expression or inducible kB-DNA binding (Ravi et al., 1998; Wadgaonkar et al., 1999; Webster et al., 1999) . One possible explanation for the discrepancy between our data and their results may be due to the dierences in cell source and/or experimental systems (e.g., vector constructs). Our data, at least, provide evidence that NF-kB binding activity is negatively regulated by the wt-p53 gene transfer in DLD-1 and LoVo cells. IkB is known to be an inhibitor protein that prevents the nuclear transport and activation of NF-kB. The activation of NF-kB depends on the detachment and/ or degradation of IkB . It has been shown that dexamethasone could increase synthesis of IkBa protein, thus reducing the amount of NF-kB that translocates to the nucleus by tumor necrosis factor-a stimulation (Scheineman et al., 1995; Auphan et al., 1995) . Wong et al. (1997) also reported that heat shock could decrease NF-kB nuclear translocation by inhibiting dissociation of IkBa from NF-kB and degradation of IkBa. We found that wt-p53 gene transfer upregulated the cytoplasmic expression of IkBa as well as its binding activity to NF-kB (Figure 2 ), suggesting that ectopically transduced wt-p53 decreases NF-kB nuclear translocation by increasing the cytoplasmic association between IkBa and NF-kB. Our data indicate that phosphorylation of IkBa can be speci®-cally inhibited by wt-p53, leading to suppress the removal of IkB from NF-kB complex. Alternatively, p53 may up-regulate IkBa by a direct protein ± protein interaction, because the human IkBa promoter sequence contained no human p53 binding sites. The mechanisms involved in the stabilization of IkBa by wt-p53 remain to be elucidated. Shao et al. (1997) reported that human ovarian cancer cells transfected with the adenoviral E1A were highly sensitive to radiation-induced apoptosis through the inhibition of nuclear NF-kB activation, which was protected by prior NF-kB transfection. Yamagishi et al. (1997) reported that a human IkBa expression plasmid suppressed the NF-kB activity induced by irradiation and enhanced the radiosensitivity of human malignant glioma cells. Inhibiting nuclear translocation of NF-kB has been shown to sensitize cells to apoptosis induced by death-inducing ligands (Jeremias et al., 1998) . Restoration of the nuclear expression of NF-kB p65 subunit could partially, but signi®cantly block wt-p53-mediated apoptotic cell death in DLD-1 cells (Figure 3 ). Together with these ®ndings, our data indicate that a down-regulation of nuclear NF-kB expression through stabilization of cytoplasmic IkBa after wt-p53 gene transfer is a plausible mechanism for apoptosis. In addition, chemotherapeutic agents have been reported to induce NF-kB activation, which protects against apoptosis triggered by these DNAdamaging therapies (Wang et al., 1996) . We previously demonstrated that adenovirus-mediated wt-p53 gene transduction induced chemosensitivity in human lung cancer cells (Fujiwara et al., 1994b) . Our preliminary experiments showed that the restoration of the wt-p53 function reduced the amount of NF-kB that translocates to the nucleus by doxorubicin stimulation in DLD-1 cells (J Shao and T Fujiwara, unpublished data). These observations suggest that the inhibition of NF-kB activation may be involved in the p53-mediated sensitization of drug-induced apoptosis.
Nonsteroidal anti-in¯ammatory drugs (NSAIDs) such as aspirin and sulindac have been shown to have potential for colorectal cancer treatments as chemopreventive agents (Shi and Rigas, 1997). NSAIDs reduced the incidence of malignant lesions in rodent models of colorectal carcinogenesis, although the mechanism of the chemopreventive action remains unknown. Grilli et al. (1996) reported that aspirin, but not indomethacin, at concentrations comparable to those in plasma during the treatment of chronic in¯ammatory states inhibited NF-kB activation. Our present data revealed that suboptimal doses of adenovirus expressing the wt-p53 gene in combination with aspirin increase on apoptosis correlated with the decrease in constitutive NF-kB binding activity (Figure 4 ). These results suggest that patients with colorectal cancer expressing the wt-p53 gene may be more sensitive to an aspirin-based chemoprevention program; but there is as yet no clinical evidence of a correlation.
Data relating to the safety of intratumoral injections of Ad5CMVp53 vectors in non-small cell lung cancer patients are derived from phase I clinical trials of p53 gene-based replacement therapy (Swisher et al., 1999) . The initial analysis of patients receiving escalating doses of Ad5CMVp53 ranging from 10 6 to 10 11 plaqueforming units demonstrated that the most frequent adverse eect was transient fever. Therefore, concomitant aspirin administration may be bene®cial for preventing fever as well as for enhancing p53-mediated apoptosis. Prospective, randomized clinical trials are required to address this issue.
In summary, our results strongly suggest that the wtp53 gene transfer suppresses NF-kB constitutive activity, presumably by enhancing cytoplasmic IkB expression, and has synergistic eects with aspirin in inducing apoptosis, a ®nding which has signi®cant clinical implications for p53 gene therapy in human cancers.
Materials and methods
Cell lines and culture conditions
The human colon cancer cell lines DLD1-, which is homozygous for a mutation in p53 at codon 241 (ser to phe), and LoVo, which contains wt-p53, were routinely propagated in monolayer cultures in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), 25 mM HEPES, 100 units/ml penicillin, and 100 mg/ml streptomycin. The transformed embryonic kidney cell line 293 was grown in DMEM (GIBCO, Grand Island, NY, USA) with high glucose (45 g/l), supplemented with 10% FCS and penicillin/streptomycin.
Reagents
Aspirin (Sigma Chemical Co., St. Louis, MO, USA) was prepared as a 100 mM stock solution in phosphate-buered saline (PBS) and stored at 48C. PBS alone was added to control cultures.
Adenoviruses
The recombinant, replication-de®cient adenovirus vector expressing human p53 cDNA was previously constructed and characterized (Fujiwara et al., 1994b; Kagawa et al., 1997) . The resultant virus was termed Ad5CMVp53. The E1A-deleted retrovirus vector d1312 was used as a control vector. These viruses were obtained by lysing infected 293 cells. Titers of the viral stocks were determined with a plaqueforming assay using 293 cells.
Reverse transcription-polymerase chain reaction (PCR)
Total RNA was isolated from mock-, dl312-, and Ad5CMVp53-infected DLD-1 or LoVo cells using RNAzol (Cinna/BioTecx, Friendswood, TX, USA) in a single-step phenol-extraction method and used as templates. Reverse transcription was performed at 228C for 10 min and then at 428C for 20 min using 1.0 mg of RNA per reaction to ensure that the amount of ampli®ed DNA was proportional to the speci®c mRNA in the original sample. A PCR was performed with speci®c primers in volumes of 50 ml according to the manufacturer's protocol (PCR kit; Perkin-Elmer Cetus, Norwalk, CT, USA). The speci®c primers used for the promoter/p53 region of Ad5CMVp53 were CMV3 (5'-GGTGCATTGGAACGCGGAT-3') and Rev Ex3 (5'-CAAATCATCCATTGCTTGGGA-3') and GAPDH as (5'-TGAGGCTGTTGTCATACTTCT-3'). The ampli®cation reaction involved denaturation at 928C for 1 min, annealing at 588C for 1 min, and 728C for 1 min using a thermal cycle (Perkin-Elmer, Foster City, CA, USA) for 35 cycles. PCR products were resolved on 1% agarose gels and visualized by ethidium bromide staining.
Flow cytometric analysis
Trypsinized adherent and¯oating cells were collected, washed twice with cold PBS, and resuspended in PBS containing 0.1% Triton X-100 and 1 mg/RNase for 5 min at room temperature. The samples were then stained with propidium iodide at 50 mg/ml and analysed in a cell sorter (FACScan, Becton Dickinson, Mountain View, CA, USA) for DNA content. Cell debris and ®xation artifacts were gated out, and G1, S1, and G2/M populations were quanti®ed using the ModFit LT program for Mac ver. 2.0 (Verity Software House, Inc.).
Preparation of nuclear and cytoplasmic extracts
Cells were fractionated by previously described procedures (Beg et al., 1993) . Brie¯y, cells were washed in PBS, pelleted, and resuspended in lysis buer (10 mM Tris-HCl [pH 8.0], 60 mMKCl, 1 mM EDTA, 1 mM dithiothreitol, protease inhibitors, and 0.1% NP-40). After 5 min on ice, the lysates were spun at 2500 r.p.m. in a microcentrifuge at 48C for 4 min. The supernatant was then removed and spun at 14 000 r.p.m. for 5 min. The supernatants were used as cytoplasmic extracts. The pelleted nuclei from the ®rst spin were brie¯y washed in lysis buer without NP-40. The nuclear pellet was then resuspended in an equal-volume nuclear extract buer (20 mM Tris-HCl [pH 8.0], 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, and 25% glycerol). After a 10 min incubation at 48C, the nuclei were brie¯y vortexed and spun at 14 000 r.p.m. for 5 min. The supernatant was then removed and used as a nuclear extract. Protein concentrations were determined using the Bio-Rad protein determination method (Bio-Rad, Hercules, CA, USA).
Western blot analysis
Equal amounts of proteins were boiled for 5 min and electrophoresed under reducing conditions on a 12.5% (w/v) polyacrylamide gel. Proteins were electrophoretically transferred to hybond-polyvinylidence difuoride (PVDF) transfer membranes and incubated with either primary rabbit antibodies against p50 or p65 (Santa Cruz Biotech, Santa Cruz, CA, USA) followed by peroxidase-linked secondary antibody. Mouse monoclonal antibodies against human p53 (Oncogene Science, Manhasset, NY, USA), IkBa and phosphorylated IkBa (phosphorylated Ser-32) (Santa Cruz Biotech), and human actin (Amersham, Arlington Heights, IL, USA) were also used as a primary antibody. An Amersham ECL chemiluminescent Western system (Amersham, Japan) was used to detect secondary probes. The quantitated data were obtained by an image analyser and are expressed as the per cent of the density of untreated cells.
Immunoprecipitation
Cytoplasmic extracts (500 mg) were immunoprecipitated by incubation with 10 ml mouse monoclonal antibody against IkBa (Santa Cruz Biotech, Santa Cruz, CA, USA) for 2 h at 48C, followed by incubation with 20 ml protein A/G plus Agarose (Santa Cruz Biotech, Santa Cruz, CA, USA) for 2 h at 48C. The beads were washed, boiled, and then subjected to 12.5% (w/v) polyacrylamide gel. The separated proteins were analysed by Western blot with a rabbit anti-p65 antibody or a mouse anti-IkBa antibody.
Immunostaining
Semicon¯uent DLD-1 cells on tissue culture chamber slides (Nunc, Inc., Naperville, IL, USA) were ®xed with acetone and washed three times with PBS. The slides were subsequently incubated with the primary antibody against NF-kB p65 subunit or against IkBa for 1 h at 378C. After washing three times with PBS, slides were incubated with the secondary antibody,¯uorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit antibody (Jackson ImmunoResearch Lab., West Grove, PA, USA) or rhodamineconjugated goat anti-mouse antibody (Immunotech, Co., Marseille, France), for 20 min at 378C. The slides were further washed with PBS three times, then mounted with buered glycerol for¯uorescent microscopic examination.
Electrophoretic mobility shift assay (EMSA)
An EMSA was performed according to the manufacturer's protocol (GelShift TM assay kit; Stratagene, La Jolla, CA, USA). A double-stranded oligonucleotide containing the NFkB-binding site (5'-GAT CGA GGG GAC TTT CCC TAG C-3') was end-labeled with g-32 P-ATP and used as a probe. Oligonucleotides for SP-1 and AP-1 (SP-1: 5'-GAT CGA TCG GGG CGG GGC GAT C-3'; AP-1: 5'-CTA GTG ATG AGT CAG CCG GAT C-3') were also used. The binding reaction of 5 mg nuclear extract and 32 P-labeled DNA was performed in the incubation buer on ice for 30 min. The resulting complexes were resolved in the polyacrylamide gel. Gels were dried and the DNA-protein complexes were visualized by autoradiography. For supershift assay, preincubation was performed with 2 ml of anti-p50 or 4 ml of anti-p65 antibody for 1 h on ice.
Plasmid construction and gene transfer
To construct an expression plasmid for NF-kB p65, a fragment of the human p65 cDNA was isolated and then inserted into pcDNA3.1(+) plasmid (Invitrogen Corporation, Carlsbad, CA, USA) with HindIII andXbaI enzymes. The resultant plasmid was named pcDNA3.1(+)/p65. DLD-1 cells were plated at a density of 2610 5 cells/well in a sixwell plate and incubated until the cells were 70% con¯uent. A mixture of 2 mg of pcDNA3.1(+) plasmid containing NFkB p65 cDNA or control plasmids pcDNA3.1(+) without p65 expression and 25 ml of LipofectACE TM Reagent (Life Technologies, Inc., Grand Island, NY, USA) in 200 ml of serum-free medium was then added to the culture according to the manufacturer's protocol. Transfected DLD-1 cells were selected in medium supplemented with 500 mg/ml of geneticin (Sigma Chemical Co., St. Louis, MO, USA) for at least 30 days. The transfected cultures were assessed for expression of sucient levels of NF-kB by immunohistochemical analysis using anti-p65 antibody.
Abbreviations wt-p53, wild-type p53; NF-kB, nuclear factor kB; CMV, cytomegalovirus; MOI, multiplicity of infection; EMSA, electrophoretic mobility shift assay; NSAID, nonsteroidal anti-in¯ammatory drugs.
